Jan Peter Ernst Christensson
Financieel Directeur/CFO bij CanImGuide Therapeutics AB
Oorsprong van het eerstegraads netwerk van Jan Peter Ernst Christensson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jan Peter Ernst Christensson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ABLIVA AB | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| UCB | Pharmaceuticals: Major | Sales & Marketing | |
| GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Operating Officer | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree | |
Setterwalls Advokatbyrå AB
 Setterwalls Advokatbyrå AB Miscellaneous Commercial ServicesCommercial Services Setterwalls Advokatbyrå AB provides legal advisory services. The company was founded in 1878 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| Chalmers University of Technology | College/University | Graduate Degree | |
| University of Uppsala | College/University | Masters Business Admin | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Corporate Officer/Principal | |
| University of Lund | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
Ernst & Young AB
 Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Ernst & Young AB provides tax advisory, auditing, and accounting services. It also offers support and advice on risk management, information technology security, and financial and business management. The company was founded in 1949 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Gothenburg | College/University | Graduate Degree | |
| DESTINY PHARMA PLC | Pharmaceuticals: Major | Chief Executive Officer | |
| Stricent AB | Chief Executive Officer | ||
| EQL PHARMA AB | Pharmaceuticals: Generic | Chairman | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Pergamum AB
 Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GW Research Ltd.
 GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Research UK Ltd. is a company that engages in researching and developing biotechnology. Jazz Pharmaceuticals Research UK Ltd. is based in Cambridge, UK. Founded in 1995. | Miscellaneous Commercial Services | Director/Board Member | |
| LIDDS AB | Pharmaceuticals: Major | Chief Executive Officer | |
First Qatar Real Estate Development Co. KSCC
 First Qatar Real Estate Development Co. KSCC Real Estate DevelopmentFinance First Qatar Real Estate Development Co. KSCC provides real estate development and asset management services. Its services include real estate development, finance and investment, property management and facility management, property feasibility studies, sales, promotion and marketing, sales agent network, design concept and interior design, project and construction management, hospitality and leisure. The company was founded in 2005 and is headquartered in Kuwait City, Kuwait. | Real Estate Development | Corporate Officer/Principal | |
| Business School Lausanne | College/University | Masters Business Admin | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Operating Officer | |
| XINTELA AB | Biotechnology | Director/Board Member Chairman | |
| ABB LLC (Qatar) | Director of Finance/CFO | ||
| Pulsetten AB | Chief Executive Officer | ||
| COMBIGENE AB | Pharmaceuticals: Major | Chief Executive Officer | |
| Capish Health Care | Corporate Officer/Principal | ||
RhoVac ApS
 RhoVac ApS Pharmaceuticals: MajorHealth Technology Part of Chosa Oncology AB, RhoVac ApS is a Danish company that aims to prevent cancer recurrence and progression after primary tumor therapy. The company is based in Hørsholm, Denmark. The company's clinical phase II product, iCIP™ - Precision LiPlaCis® & DRP® with Breakthrough designation option, consists of LiPlaCis® and its Drug Response. Anders Månsson has been the CEO of the company since 2019. | Pharmaceuticals: Major | Chief Executive Officer | |
| INTELLEGO TECHNOLOGIES AB | Electronic Components | Chairman | |
| PHARMIVA AB (PUBL) | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Panion Animal Health AB
 Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Agricultural Commodities/Milling | Director/Board Member | |
Trophea AB
 Trophea AB Miscellaneous Commercial ServicesCommercial Services Trophea AB provides medical need for a treatment of skin atrophy caused by long-term use of topical glucocorticoids. The company is headquartered in Helsingborg, Sweden. | Miscellaneous Commercial Services | Founder | |
ImmuneBiotech Medical Sweden AB
 ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chairman | |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Chairman | |
Asgard Therapeutics AB
 Asgard Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Asgard Therapeutics AB engages in biotechnological research and development activities. It is in use of cellular reprogramming in cancer immunotherapy, which forces cancer cells to present their own antigens to the immune system, triggering expansion of cancer cell-specific killer T cells and cancer elimination. The company was founded by Filipe Pereira, Cristiana Pires and Fábio Rosa in 2018 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chairman | |
GW Pharma Ltd.
 GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Histon, UK. GW Pharma was founded in 1999. | Pharmaceuticals: Major | Director/Board Member | |
| Urbicum Ledningskonsult AB | Director/Board Member | ||
| AMNIOTICS AB | Biotechnology | Chief Executive Officer | |
CarryGenes Therapeutics AB
 CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| OVB Freehold Ltd. | Director/Board Member | ||
| Immodulate Pharma AB | Director/Board Member Director/Board Member Director/Board Member | ||
| Anders Månsson Business Development AB | Chief Executive Officer | ||
| Neurovive Pharmaceutical AB | Chief Executive Officer | ||
| Lundoch Diagnostics AB | Chairman |
Statistieken
Internationaal
| Zweden | 37 |
| Verenigd Koninkrijk | 8 |
| Denemarken | 3 |
| België | 2 |
| Koeweit | 2 |
Sectoraal
| Health Technology | 23 |
| Commercial Services | 9 |
| Consumer Services | 8 |
| Finance | 2 |
| Electronic Technology | 2 |
Operationeel
| Director/Board Member | 41 |
| Chairman | 23 |
| Corporate Officer/Principal | 21 |
| Chief Executive Officer | 19 |
| Founder | 5 |
Sterkste connecties
- Beurs
- Insiders
- Jan Peter Ernst Christensson
- Bedrijfsconnecties
